Search

Author/Creator Advani, A.

1. Adding Molecular Data to Prognostic Models can Improve their Predictive Power in Treated Patients with Myelodysplastic Syndromes (MDS). (April 2017)

Authors:
Nazha, A.; Al-Issa, K.; Zarzour, A.; Radivoyevitch, T.; Hamilton, B.; Gerds, A.; Mukherjee, S.; Adema, V.; Clemente, M.; Patel, B.; Hirsch, C.; Advani, A.; Bartlomiej, P.; Carraway, H.; Maciejewski, J.; Sekeres, M.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P555: A PHASE 1B/2 STUDY OF THE CD123-TARGETING ANTIBODY-DRUG CONJUGATE PIVEKIMAB SUNIRINE (IMGN632) IN COMBINATION WITH VENETOCLAX (VEN) AND AZACITIDINE (AZA) FOR PATIENTS WITH CD123-POSITIVE AML. (23rd June 2022)

Authors:
Daver, N. G.; Montesinos, P.; Aribi, A.; Martinelli, G.; Altman, J.; Roboz, G.; Wang, E. S.; Burke, P. W.; Jeyakumar, D.; Walter, R. B.; DeAngelo, D. J.; Erba, H. P.; Advani, A.; Gastaud, L.; Thomas, X.; Todisco, E.; Pemmaraju, N.; Mendez, L.; de la Fuente, A.; Gaidano, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
454
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗